[2/2] RECALL: Sandoz is voluntarily recalling prescription oral #ranitidine products while work continues internationally to assess #NDMA in drugs: https://t.co/yeFWEqHhPQ

— GovCanHealth (@GovCanHealth) September 18, 2019